Table 1.

Growth inhibition of human HCC-derived cell lines with Bortezomib

HCC cell lineIC50 (nmol/L)95% CI
HuH72.42.2-2.7
Hep3B7.76.4-8.8
HepG23.93.4-4.0
PLC/PRF/53.63.5-3.8
  • NOTE: IC50, 50% growth inhibition determined by sulforhodamin B-assay.

    Abbreviation: 95% CI, 95% confidence intervals.